Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Web site created using create-react-app Short interest in Recursion Pharmaceuticals Inc (NASDAQ:RXRX) decreased during the last reporting period, falling from 173.17M to 168.52M. This put 34.3% of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results